Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
123.50    0.00 (0.00%)
Bid:
122.00
Ask:
125.00
Spread: 3.00 (2.459%)
Market Cap: £41.18m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Additional Subscription and Total Voting Rights

21 Jul 2025 07:00

RNS Number : 8311R
Onward Opportunities Limited
21 July 2025
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

21 July 2025

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

Additional Subscription and Total Voting Rights

 

Onward Opportunities Limited, the UK smaller company focussed investment company, is pleased to announce that, further to the announcement of 7.00 a.m. on 16 July 2025, in response to investor demand it has raised additional gross proceeds of approximately £0.6 million by way of an additional direct subscription (the "Additional Subscription") for 452,698 new ordinary shares (the "Additional Subscription Shares") at a price of 126.64 pence per Additional Subscription Share.

 

The Subscription and Additional Subscription, in aggregate, raised gross proceeds of £2.0 million. The net proceeds of which, being approximately £1.93 million, will provide the Company with additional resources with which to pursue its stated investing policy.

 

Pursuant to the Additional Subscription, application has been made for the Additional Subscription Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around 23 July 2025 and the Additional Subscription Shares will, on issue, rank pari passu in all respects with the Company's existing ordinary shares.

 

Total Voting Rights

 

On Admission, the Company will have a total of 27,251,521 ordinary shares in issue. No ordinary shares are held in treasury. The figure of 27,251,521 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Concert Party

 

On Admission, the members of the Concert Party in the Company will collectively hold an aggregate of 11,407,204 ordinary shares in the Company, representing 41.9 per cent. of the Company's enlarged issued ordinary share capital, of which the Portfolio Manager holds 10,011,089 ordinary shares, representing 36.7 per cent. of the Company's enlarged issued ordinary share capital, on behalf of its discretionary clients.

 

Capitalised terms not otherwise defined in the text of this announcement have the same meanings ascribed to them as in the "Issue of Equity" announcement published by the Company at 7.00 a.m. on 16 July 2025.

 

FOR FURTHER ENQUIRIES

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Lead Fund Manager

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Hamish Waller - Corporate Finance

Chris West / Matt Lewis - Sales and Corporate Broking

 

Tel: +44 (0)20 7220 0500

Dowgate Capital Limited (Joint Broker)

Nicholas Chambers / Daniel Ingram

 

Tel: +44 (0)20 3903 7715

 

To find out more, please visit: www.onwardopportunities.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEKZGZNKMVGKZG
12
Date   Source Headline
13th Nov 202510:32 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSIssue of Equity
4th Nov 20257:00 amRNSNet Asset Value(s)
16th Oct 20254:54 pmRNSHolding(s) in Company
14th Oct 20251:09 pmRNSPublication of Q3 2025 Factsheet
10th Oct 20257:00 amRNSAdditional Subscription and Total Voting Rights
7th Oct 20257:00 amRNSIssue of Equity
1st Oct 20253:33 pmRNSNet Asset Value(s)
8th Sep 20257:00 amRNSHalf-year Report
2nd Sep 20257:00 amRNSNet Asset Value(s)
4th Aug 202512:57 pmRNSNet Asset Value(s)
25th Jul 202510:05 amRNSHolding(s) in Company
24th Jul 20257:00 amRNSHalf-Year Update
21st Jul 20257:00 amRNSAdditional Subscription and Total Voting Rights
16th Jul 20257:00 amRNSIssue of Equity
7th Jul 20257:00 amRNSPublication of Q2 2025 Factsheet
2nd Jul 20253:47 pmRNSNet Asset Value(s)
16th Jun 202512:49 pmRNSResult of AGM
3rd Jun 20257:00 amRNSNet Asset Value
2nd Jun 20257:00 amRNS-RInaugural Investor Day
29th May 20257:00 amRNSNotice of AGM
7th May 20251:29 pmRNSDirector Dealing
6th May 20257:00 amRNSChange of Service Providers and Registered Office
2nd May 20259:26 amRNSNet Asset Value(s)
16th Apr 20255:33 pmRNSHolding(s) in Company
2nd Apr 20252:50 pmRNSNet Asset Value(s)
20th Mar 20257:00 amRNSAdditional Subscription and Total Voting Rights
18th Mar 20257:00 amRNSAnnual Results
14th Mar 20257:00 amRNSIssue of Equity and Total Voting Rights
11th Mar 20255:02 pmRNSHolding(s) in Company
4th Mar 20254:59 pmRNSNet Asset Value(s)
4th Feb 20255:10 pmRNSHolding(s) in Company
4th Feb 20251:46 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSAmalgamation of Administrator
16th Jan 20257:00 amRNSPublication of Q4 2024 Factsheet
14th Jan 20257:00 amRNSFull-Year Update
2nd Jan 20255:50 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSAdditional Subscription and Total Voting Rights
4th Dec 20247:00 amRNSIssue of Equity
2nd Dec 20245:38 pmRNSNet Asset Value(s)
1st Nov 20244:42 pmRNSNet Asset Value(s)
30th Oct 20244:40 pmRNSHolding(s) in Company
24th Oct 202412:00 pmRNSIssue of Equity
11th Oct 20247:00 amRNSPublication of Q3 2024 Factsheet
3rd Oct 20243:44 pmRNSHolding(s) in Company
2nd Oct 20244:34 pmRNSNet Asset Value(s)
26th Sep 20243:27 pmRNSAdditional Subscription and Total Voting Rights
26th Sep 20247:00 amRNSIssue of Equity
6th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20244:21 pmRNSNet Asset Value
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.